Clinical Trial Update: Study of Chemotherapy Sequenced by or Combined With EGFR-TKIs for NSCLC Patients Failed to EGFR-TKIs Therapy [Phase 2]

View source ↗

Summary

This Phase 2 trial investigates sequencing or combination of chemotherapy with EGFR-TKIs in non-small cell lung cancer patients who failed prior EGFR-TKI therap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• EGFR Tyrosine Kinase Inhibitors (EGFR tyrosine kinase inhibitor)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN